Moss RA - Search Results

1

Exercise therapy for tendinopathy: a mixed-methods evidence synthesis exploring feasibility, acceptability and effectiveness.

Cooper K, Alexander L, Brandie D, Brown VT, Greig L, Harrison I, MacLean C, Mitchell L, Morrissey D, Moss RA, Parkinson E, Pavlova AV, Shim J, Swinton PA. Cooper K, et al. Among authors: moss ra. Health Technol Assess. 2023 Oct;27(24):1-389. doi: 10.3310/TFWS2748. Health Technol Assess. 2023. PMID: 37929629 Free PMC article.

2

What are small, medium and large effect sizes for exercise treatments of tendinopathy? A systematic review and meta-analysis.

Swinton PA, Shim JSC, Pavlova AV, Moss R, Maclean C, Brandie D, Mitchell L, Greig L, Parkinson E, Tzortziou Brown V, Morrissey D, Alexander L, Cooper K. Swinton PA, et al. BMJ Open Sport Exerc Med. 2023 Feb 27;9(1):e001389. doi: 10.1136/bmjsem-2022-001389. eCollection 2023. BMJ Open Sport Exerc Med. 2023. PMID: 36865768 Free PMC article.

3

Effect of resistance exercise dose components for tendinopathy management: a systematic review with meta-analysis.

Pavlova AV, Shim JSC, Moss R, Maclean C, Brandie D, Mitchell L, Greig L, Parkinson E, Alexander L, Tzortziou Brown V, Morrissey D, Cooper K, Swinton PA. Pavlova AV, et al. Br J Sports Med. 2023 Oct;57(20):1327-1334. doi: 10.1136/bjsports-2022-105754. Epub 2023 May 11. Br J Sports Med. 2023. PMID: 37169370 Free PMC article.

4

Investigating Scottish Long COVID community rehabilitation service models from the perspectives of people living with Long COVID and healthcare professionals: a qualitative descriptive study.

Duncan E, Alexander L, Cowie J, Love A, Morris JH, Moss R, Ormerod J, Preston J, Shim J, Stage E, Tooman T, Cooper K. Duncan E, et al. BMJ Open. 2023 Dec 14;13(12):e078740. doi: 10.1136/bmjopen-2023-078740. BMJ Open. 2023. PMID: 38101833 Free PMC article.

5

Exposure to ecologically relevant estrogen levels do not influence morphology or immune parameters in hatchling American alligators (Alligator mississippiensis).

Moss RA, Murphy KM, Gardner ST, Watkins MM, Finger JW Jr, Kelley MD, Elsey RM, Warner DA, Mendonça MT. Moss RA, et al. Comp Biochem Physiol C Toxicol Pharmacol. 2024 Jan;275:109767. doi: 10.1016/j.cbpc.2023.109767. Epub 2023 Oct 10. Comp Biochem Physiol C Toxicol Pharmacol. 2024. PMID: 37827394

6

Patient ratings in exercise therapy for the management of tendinopathy: a systematic review with meta-analysis.

Shim J, Pavlova AV, Moss RA, MacLean C, Brandie D, Mitchell L, Greig L, Parkinson E, Tzortziou Brown V, Morrissey D, Alexander L, Cooper K, Swinton PA. Shim J, et al. Among authors: moss ra. Physiotherapy. 2023 Sep;120:78-94. doi: 10.1016/j.physio.2023.05.002. Epub 2023 Jun 7. Physiotherapy. 2023. PMID: 37406460 Free article. Review.

7

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors.

Kluger H, Barrett JC, Gainor JF, Hamid O, Hurwitz M, LaVallee T, Moss RA, Zappasodi R, Sullivan RJ, Tawbi H, Sharon E. Kluger H, et al. Among authors: moss ra. J Immunother Cancer. 2023 Mar;11(3):e005921. doi: 10.1136/jitc-2022-005921. J Immunother Cancer. 2023. PMID: 36918224 Free PMC article.

8

A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients.

Berenson JR, Kim C, Bujarski S, To J, Spektor TM, Martinez D, Turner C, Ghermezi M, Eades BM, Swift RA, Schwartz G, Eshaghian S, Moss RA, Lim S, Vescio R. Berenson JR, et al. Among authors: moss ra. Hematol Oncol. 2022 Dec;40(5):906-913. doi: 10.1002/hon.3066. Epub 2022 Aug 14. Hematol Oncol. 2022. PMID: 35946431 Clinical Trial.

9

Web Exclusive. Annals Story Slam - I Know Them by Name.

Moss RA. Moss RA. Ann Intern Med. 2022 Jun;175(6):SS1. doi: 10.7326/W22-0006. Epub 2022 Apr 29. Ann Intern Med. 2022. PMID: 35486120 Free article. No abstract available.

10

A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.

Tan AR, Chan N, Kiesel BF, Stein MN, Moss RA, Malhotra J, Aisner J, Shah M, Gounder M, Lin H, Kane MP, Lin Y, Ji J, Chen A, Beumer JH, Mehnert JM. Tan AR, et al. Among authors: moss ra. Cancer Chemother Pharmacol. 2022 Jan;89(1):49-58. doi: 10.1007/s00280-021-04350-x. Epub 2021 Oct 20. Cancer Chemother Pharmacol. 2022. PMID: 34669023 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page